How Moderna's COVID-19 Vaccine Compares To Pfizer's
The Massachusetts-based biotechnology company Moderna announced Monday that its potential COVID-19 vaccine has proven 94.5 percent effective during a trial, making it the second possible coronavirus vaccine to have a high success rate. How does it compare to Pfizer's vaccine?